| Package: | 30tablets/Box |
|---|---|
| Composition: | Letrozole |
| Transport Package: | Free |
| Specification: | 2.5mg |
| Trademark: | Sinolead |
| Origin: | China |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
| Product | Dose | Package |
| Letrozole Tablets | 2.5mg | 30Tablets/box |
Letrozole Tablets belong to a class of medications known as aromatase inhibitors. They are primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women and for ovulation induction in women with infertility due to anovulation or polycystic ovary syndrome (PCOS).
Breast Cancer: Letrozole Tablets are indicated for the adjuvant treatment of early-stage hormone receptor-positive breast cancer in postmenopausal women, as well as for the treatment of advanced breast cancer in postmenopausal women who have received prior hormonal therapy.
Infertility: Letrozole may be prescribed off-label for ovulation induction in women with infertility due to anovulation or PCOS who have not responded to other ovulation-inducing medications.
Letrozole Tablets are taken orally with water, usually once daily. The dosage and duration of treatment depend on the patient's condition, response to therapy, and treatment goals.
In breast cancer treatment, letrozole may be used as adjuvant therapy following surgery or as palliative therapy for advanced disease.
Safety and Considerations:
Letrozole should not be used in premenopausal women, as it may cause ovarian suppression and infertility.
Regular monitoring of bone mineral density and cholesterol levels is recommended during letrozole therapy, as it may increase the risk of osteoporosis and hypercholesterolemia.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}